Company · CIK 0001629137
Global Blood Therapeutics, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SC 13G/AGlobal Blood Therapeutics, Inc.0001172661-23-000829 · 102.9 KBSEC(opens sec.gov)
- SC 13G/AGlobal Blood Therapeutics, Inc.0000315066-23-001628 · 8.1 KBSEC(opens sec.gov)
- 8-KCurrent report0000950157-22-001085 · 361.3 KBSEC(opens sec.gov)
- 8-KCurrent report0000950157-22-001076 · 183.2 KBSEC(opens sec.gov)
- 8-KCurrent report0000950157-22-001050 · 248.0 KBSEC(opens sec.gov)
- 10-QQuarterly update0000950170-22-015231 · 12.1 MBSEC(opens sec.gov)
- 8-KCurrent report0000950157-22-000902 · 976.6 KBSEC(opens sec.gov)
- 8-KCurrent report0001171843-22-004988 · 240.6 KBSEC(opens sec.gov)
- 8-KCurrent report0001171843-22-004853 · 234.0 KBSEC(opens sec.gov)
- 8-KCurrent report0001171843-22-004591 · 231.6 KBSEC(opens sec.gov)
Insiders
- BONNEY MICHAEL WDirector
- Brown Willie L. Jr.Director
- Calhoun Lesley AnnSee Remarks
- CATHERS BRIAN EDWINChief Scientific Officer
- Choi JungSee Remarks
- EDELMAN JOSEPHFormer 10% Owner
- Farrow Jeffrey SChief Financial Officer
- Fink EricChief Human Resources Officer
- Habibizad NazilaSee Remarks
- HOMCY CHARLES JDirector
Tickers
No tickers on record.
Addresses
business
181 OYSTER POINT BLVD
SOUTH SAN FRANCISCO, CA, 94080
mailing
181 OYSTER POINT BLVD
SOUTH SAN FRANCISCO, CA, 94080
Same industry